Hodi, F Stephen : rechercher sur Z-Library

Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Campagne de collecte 15 septembre 2024 – 1 octobre 2024

Z-Library est une des plus grandes bibliothèques en ligne dans le monde, avec le stockage de plus de 17,000,000 livres et plus de 84,837,000 articles. Nous encourageons l'accès libre de chacun à la littérature. Aujourd'hui (15 septembre 2024) nous faisons un appel de fonds à tous ceux qui veulent contribuer encore plus au soutien et au développement de notre projet.

Les téléchargements SANS LIMITE sont aussi (au cours de 31 jours après la date de don) disponibles pour TOUS les utilisateurs qui soient en mesure de soutenir le projet pendant la période de collecte de fonds jusqu'au 1 octobre 2024.

C'est quoi, la collecte de fonds?En savoir plus

Livres
Articles (163)
Les plus populaires
Liste
- Liste
- Tableau

1

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Topalian, Suzanne L., Hodi, F. Stephen, Brahmer, Julie R., Gettinger, Scott N., Smith, David C., McDermott, David F., Powderly, John D., Carvajal, Richard D., Sosman, Jeffrey A., Atkins, Michael B., L

Journal:

Boston Medical and Surgical Journal

Année:

2012

Langue:

english

Fichier:

PDF, 684 KB

english, 2012

2

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Robert, Caroline, Ribas, Antoni, Wolchok, Jedd D, Hodi, F Stephen, Hamid, Omid, Kefford, Richard, Weber, Jeffrey S, Joshua, Anthony M, Hwu, Wen-Jen, Gangadhar, Tara C, Patnaik, Amita, Dronca, Roxana,

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 364 KB

english, 2014

3

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Hamid, Omid, Robert, Caroline, Daud, Adil, Hodi, F. Stephen, Hwu, Wen-Jen, Kefford, Richard, Wolchok, Jedd D., Hersey, Peter, Joseph, Richard W., Weber, Jeffrey S., Dronca, Roxana, Gangadhar, Tara C.,

Journal:

Boston Medical and Surgical Journal

Année:

2013

Langue:

english

Fichier:

PDF, 701 KB

english, 2013

4

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

Wolchok, Jedd D., Hodi, F. Stephen, Weber, Jeffrey S., Allison, James P., Urba, Walter J., Robert, Caroline, O'Day, Steven J., Hoos, Axel, Humphrey, Rachel, Berman, David M., Lonberg, Nils, Korman, Al

Journal:

Annals of the New York Academy of Sciences

Année:

2013

Langue:

english

Fichier:

PDF, 733 KB

english, 2013

5

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Weber, Jeffrey S, D'Angelo, Sandra P, Minor, David, Hodi, F Stephen, Gutzmer, Ralf, Neyns, Bart, Hoeller, Christoph, Khushalani, Nikhil I, Miller, Wilson H, Lao, Christopher D, Linette, Gerald P, Thom

Journal:

The Lancet Oncology

Année:

2015

Langue:

english

Fichier:

PDF, 556 KB

english, 2015

6

CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS

Hodi, F Stephen, Oble, Darryl A, Drappatz, Jan, Velazquez, Elsa F, Ramaiya, Nikhil, Ramakrishna, Naren, Day, Arthur L, Kruse, Andrea, Rae, Suzanne Mac, Hoos, Axel, Mihm, Martin

Journal:

Nature Clinical Practice Oncology

Année:

2008

Langue:

english

Fichier:

PDF, 724 KB

english, 2008

7

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Ribas, Antoni, Puzanov, Igor, Dummer, Reinhard, Schadendorf, Dirk, Hamid, Omid, Robert, Caroline, Hodi, F Stephen, Schachter, Jacob, Pavlick, Anna C, Lewis, Karl D, Cranmer, Lee D, Blank, Christian U,

Journal:

The Lancet Oncology

Année:

2015

Langue:

english

Fichier:

PDF, 411 KB

english, 2015

8

RECIST 1.1—Update and clarification: From the RECIST committee

Schwartz, Lawrence H., Litière, Saskia, de Vries, Elisabeth, Ford, Robert, Gwyther, Stephen, Mandrekar, Sumithra, Shankar, Lalitha, Bogaerts, Jan, Chen, Alice, Dancey, Janet, Hayes, Wendy, Hodi, F. St

Journal:

European Journal of Cancer

Année:

2016

Langue:

english

Fichier:

PDF, 679 KB

english, 2016

9

α-CTLA-4 mAb-associated Panenteritis

Oble, Darryl A., Mino-Kenudson, Mari, Goldsmith, Jeffrey, Hodi, F. Stephen, Seliem, Rania M., Dranoff, Glenn, Mihm, Martin, Hasserjian, Robert, Lauwers, Gregory Y.

Journal:

American Journal of Surgical Pathology

Année:

2008

Langue:

english

Fichier:

PDF, 875 KB

english, 2008

10

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Seymour, Lesley, Bogaerts, Jan, Perrone, Andrea, Ford, Robert, Schwartz, Lawrence H, Mandrekar, Sumithra, Lin, Nancy U, Litière, Saskia, Dancey, Janet, Chen, Alice, Hodi, F Stephen, Therasse, Patrick,

Journal:

The Lancet Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 310 KB

english, 2017

11

Tumor response dynamics of advanced non-small-cell lung cancer patients treated with PD-1 inhibitors: Imaging markers for treatment outcome

Nishino, Mizuki, Dahlberg, Suzanne E., Adeni, Anika E, Lydon, Christine, Hatabu, Hiroto, Janne, Pasi A., Hodi, F. Stephen, Awad, Mark M.

Journal:

Clinical Cancer Research

Année:

2017

Langue:

english

Fichier:

PDF, 3.58 MB

english, 2017

12

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

Hodi, Frank Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Cowey, Charles Lance, Lao, Christopher D, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferruc

Journal:

The Lancet Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 1.31 MB

english, 2018

13

Imaging of Cancer Immunotherapy: Current Approaches and Future Directions

Nishino, Mizuki, Hatabu, Hiroto, Hodi, F. Stephen

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 1.69 MB

english, 2018

14

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

Schadendorf, Dirk, Wolchok, Jedd D., Hodi, F. Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher D., Chesney, Jason, Robert, Carol

Journal:

Journal of Clinical Oncology

Année:

2017

Fichier:

PDF, 1005 KB

2017

15

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy

Hodi, F. Stephen, Ballinger, Marcus, Lyons, Benjamin, Soria, Jean-Charles, Nishino, Mizuki, Tabernero, Josep, Powles, Thomas, Smith, David, Hoos, Axel, McKenna, Chris, Beyer, Ulrich, Rhee, Ina, Fine,

Journal:

Journal of Clinical Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 646 KB

english, 2018

16

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Ribas, Antoni, Lawrence, Donald, Atkinson, Victoria, Agarwal, Sachin, Miller, Wilson H., Carlino, Matteo S., Fisher, Rosalie, Long, Georgina V., Hodi, F. Stephen, Tsoi, Jennifer, Grasso, Catherine S.,

Journal:

Nature Medicine

Année:

2019

Langue:

english

Fichier:

PDF, 1.82 MB

english, 2019

17

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Tarhini, Ahmad A., Lee, Sandra J., Hodi, F. Stephen, Rao, Uma N. M., Cohen, Gary I., Hamid, Omid, Hutchins, Laura F., Sosman, Jeffrey A., Kluger, Harriett M., Eroglu, Zeynep, Koon, Henry B., Lawrence,

Journal:

Journal of Clinical Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 653 KB

english, 2019

18

Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases

Qian, Jack M., Martin, Allison M., Martin, Kate, Hammoudeh, Lubna, Catalano, Paul J., Hodi, F. Stephen, Cagney, Daniel N., Haas-Kogan, Daphne A., Schoenfeld, Jonathan D., Aizer, Ayal A.

Journal:

Année:

2020

Fichier:

PDF, 265 KB

2020

19

Melanoma

Hodi, F. Stephen

Journal:

Hematology/Oncology Clinics of North America

Année:

2021

Fichier:

PDF, 267 KB

2021

20

Prevalence of antibodies to 3 retroviruses in a captive colony of macaque monkeys

Muthiah D. Daniel, Norman L. Letvin, Prabhat K. Sehgal, Diane K. Schmidt, Daniel P. Silva, Keith R. Solomon, F. Stephen Hodi, Jr. Douglas J. Ringler, Ronald D. Hunt, Norval W. King, Ronald C. Desrosie

Journal:

International Journal of Cancer

Année:

1988

Langue:

english

Fichier:

PDF, 1019 KB

english, 1988

21

The biologic importance of tumor-infiltrating lymphocytes

F. Stephen Hodi, Glenn Dranoff

Journal:

Journal of Cutaneous Pathology

Année:

2010

Langue:

english

Fichier:

PDF, 548 KB

english, 2010

22

Overcoming immunological tolerance to melanoma: Targeting CTLA-4

Journal:

Asia-Pacific Journal of Clinical Oncology

Année:

2010

Langue:

english

Fichier:

PDF, 241 KB

english, 2010

23

CTLA-4 to overcome immunological tolerance to melanoma

Journal:

Asia-Pacific Journal of Clinical Oncology

Année:

2011

Langue:

english

Fichier:

PDF, 99 KB

english, 2011

24

Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines

Masahisa Jinushi, F. Stephen Hodi, Glenn Dranoff

Journal:

Immunological Reviews

Année:

2008

Langue:

english

Fichier:

PDF, 425 KB

english, 2008

25

Targeted Therapeutics in Melanoma Volume 202 || Melanoma Vaccines

Gajewski, Thomas F., Hodi, F. Stephen

Année:

2012

Langue:

english

Fichier:

PDF, 363 KB

english, 2012

26

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma

Jun Zhou, Noah K. Yuen, Qian Zhan, Elsa F. Velazquez, George F. Murphy, Anita Giobbie-Hurder, F. Stephen Hodi

Journal:

Cancer Immunology, Immunotherapy

Année:

2012

Langue:

english

Fichier:

PDF, 634 KB

english, 2012

27

Isolation of tumorigenic circulating melanoma cells

Jie Ma, Jennifer Y. Lin, Allireza Alloo, Brian J. Wilson, Tobias Schatton, Qian Zhan, George F. Murphy, Ana-Maria Waaga-Gasser, Martin Gasser, F. Stephen Hodi, Natasha Y. Frank, Markus H. Frank

Journal:

Biochemical and Biophysical Research Communications

Année:

2010

Langue:

english

Fichier:

PDF, 900 KB

english, 2010

28

Melanoma of unknown primary: experience at the dana farber-partners cancer center and review of the literature

Kenneth A. Katz, Eric Jonasch, F.Stephen Hodi, Frank Haluska

Journal:

Journal of the American Academy of Dermatology

Année:

2004

Langue:

english

Fichier:

PDF, 57 KB

english, 2004

29

Ipilimumab in patients with melanoma and brain metastases – Authors' reply

Kim Margolin, F Stephen Hodi

Journal:

The Lancet Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 43 KB

english, 2012

30

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. Stephen, O'Day, Steven J., McDermott, David F., Weber, Robert W., Sosman, Jeffrey A., Haanen, John B., Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C., Akerley, Wallac

Journal:

Boston Medical and Surgical Journal

Année:

2010

Langue:

english

Fichier:

PDF, 439 KB

english, 2010

31

T cell activation predicts carotid artery stiffness among HIV-infected women

Robert C. Kaplan, Elizabeth Sinclair, Alan L. Landay, Nell Lurain, A. Richey Sharrett, Stephen J. Gange, Xiaonan Xue, Christina M. Parrinello, Peter Hunt, Steven G. Deeks, Howard N. Hodis

Journal:

Atherosclerosis

Année:

2011

Langue:

english

Fichier:

PDF, 149 KB

english, 2011

32

The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma

Wu, Xinqi, Zhu, Meijun, Fletcher, Jonathan A., Giobbie-Hurder, Anita, Hodi, F. Stephen, Schneider, Guenter

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 1.50 MB

english, 2012

33

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

DeFronzo, Ralph A., Tripathy, Devjit, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Henry, Robert R., Hodis, Howard N., Kitabchi, Abbas E., Mack, Wend

Journal:

Boston Medical and Surgical Journal

Année:

2011

Langue:

english

Fichier:

PDF, 528 KB

english, 2011

34

Application of Protein Microarrays for Multiplexed Detection of Antibodies to Tumor Antigens in Breast Cancer

Anderson, Karen S., Ramachandran, Niroshan, Wong, Jessica, Raphael, Jacob V., Hainsworth, Eugenie, Demirkan, Gokhan, Cramer, Daniel, Aronzon, Dina, Hodi, F. Stephen, Harris, Lyndsay, Logvinenko, Tanya

Journal:

Journal of Proteome Research

Année:

2008

Langue:

english

Fichier:

PDF, 3.33 MB

english, 2008

35

The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma

Kaufman, Howard L., Kirkwood, John M., Hodi, F. Stephen, Agarwala, Sanjiv, Amatruda, Thomas, Bines, Steven D., Clark, Joseph I., Curti, Brendan, Ernstoff, Marc S., Gajewski, Thomas, Gonzalez, Rene, Hy

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Année:

2013

Langue:

english

Fichier:

PDF, 391 KB

english, 2013

36

From genes to drugs: targeted strategies for melanoma

Flaherty, Keith T., Hodi, F. Stephen, Fisher, David E.

Journal:

Nature Reviews Cancer

Année:

2012

Langue:

english

Fichier:

PDF, 466 KB

english, 2012

37

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group

Lin, Nancy U, Lee, Eudocia Q, Aoyama, Hidefumi, Barani, Igor J, Baumert, Brigitta G, Brown, Paul D, Camidge, D Ross, Chang, Susan M, Dancey, Janet, Gaspar, Laurie E, Harris, Gordon J, Hodi, F Stephen,

Journal:

The Lancet Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 1.04 MB

english, 2013

38

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

Ackerman, Allison, Klein, Oliver, McDermott, David F., Wang, Wei, Ibrahim, Nageatte, Lawrence, Donald P., Gunturi, Anasuya, Flaherty, Keith T., Hodi, F. Stephen, Kefford, Richard, Menzies, Alexander M

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 184 KB

english, 2014

39

Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study

Parrinello, Christina M., Landay, Alan L., Hodis, Howard N., Gange, Stephen J., Norris, Philip J., Young, Mary, Anastos, Kathryn, Tien, Phyllis C., Xue, Xiaonan, Lazar, Jason, Benning, Lorie, Tracy, R

Journal:

Atherosclerosis

Année:

2012

Langue:

english

Fichier:

PDF, 117 KB

english, 2012

40

A Primate Species with Limited Major Histocompatibility Complex Class I Polymorphism

David I. Watkins, F. Stephen Hodi and Norman L. Letvin

Journal:

Proceedings of the National Academy of Sciences

Année:

1988

Langue:

english

Fichier:

PDF, 1.01 MB

english, 1988

41

Vaccination with Irradiated Autologous Melanoma Cells Engineered to Secrete Human Granulocyte--Macrophage Colony-Stimulating Factor Generates Potent Antitumor Immunity in Patients with Metastatic Melanoma

Robert Soiffer, Thomas Lynch, Martin Mihm, Ken Jung, Catherine Rhuda, Jan C. Schmollinger, F. Stephen Hodi, Laura Liebster, Prudence Lam, Steven Mentzer, Samuel Singer, Kenneth K. Tanabe, A. Benedict

Journal:

Proceedings of the National Academy of Sciences

Année:

1998

Langue:

english

Fichier:

PDF, 2.00 MB

english, 1998

42

Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab

Weber, Jeffrey S., Dummer, Reinhard, de Pril, Veerle, Lebbé, Celeste, Hodi, F. Stephen

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 300 KB

english, 2013

43

Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma

Hodi, F Stephen, Fisher, David E

Journal:

Nature Clinical Practice Oncology

Année:

2008

Langue:

english

Fichier:

PDF, 164 KB

english, 2008

44

Hepatotoxicity with Combination of Vemurafenib and Ipilimumab

Ribas, Antoni, Hodi, F. Stephen, Callahan, Margaret, Konto, Cyril, Wolchok, Jedd

Journal:

Boston Medical and Surgical Journal

Année:

2013

Langue:

english

Fichier:

PDF, 331 KB

english, 2013

45

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

Nishino, Mizuki, Giobbie-Hurder, Anita, Ramaiya, Nikhil H, Hodi, F Stephen

Journal:

Journal for ImmunoTherapy of Cancer

Année:

2014

Langue:

english

Fichier:

PDF, 1.27 MB

english, 2014

46

Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma

Zukotynski, Katherine, Yap, Jeffrey T, Giobbie-Hurder, Anita, Weber, Jeffrey, Gonzalez, Rene, Gajewski, Thomas F, O’Day, Steven, Kim, Kevin, Hodi, F Stephen, Van den Abbeele, Annick D

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 796 KB

english, 2014

47

Subverting the B7-H1/PD-1 Pathway in Advanced Melanoma and Kidney Cancer

Harshman, Lauren C., Choueiri, Toni K., Drake, Charles, Stephen Hodi, F.

Journal:

The Cancer Journal

Année:

2014

Langue:

english

Fichier:

PDF, 805 KB

english, 2014

48

c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential

Wu, Xinqi, Zhou, Jun, Rogers, Andrew M., Jänne, Pasi A., Benedettini, Elisa, Loda, Massimo, Hodi, F. Stephen

Journal:

Melanoma Research

Année:

2012

Langue:

english

Fichier:

PDF, 516 KB

english, 2012

49

Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment

Nishino, Mizuki, Tirumani, Sree H., Ramaiya, Nikhil H., Hodi, F. Stephen

Journal:

European Journal of Radiology

Année:

2015

Langue:

english

Fichier:

PDF, 1.34 MB

english, 2015

50

Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma

Hodi, F. Stephen, Lee, Sandra, McDermott, David F., Rao, Uma N., Butterfield, Lisa H., Tarhini, Ahmad A., Leming, Philip, Puzanov, Igor, Shin, Donghoon, Kirkwood, John M.

Journal:

JAMA The Journal of the American Medical Association

Année:

2014

Langue:

english

Fichier:

PDF, 386 KB

english, 2014